倍他乐克治疗55例高血压病的疗效观察  

Clinical observation on Betook in treatment of 55 patients with hypertension

作　　者：王红梅 

机构地区：[1]安徽省宿州第一人民医院,234000

出　　处：《中国医学创新》2009年第19期9-10,共2页Medical Innovation of China

摘　　要：目的探讨酒石酸美托洛尔（倍他乐克）治疗高血压患者的效果。方法将高血压患者110例随机分为治疗组和对照组，治疗组给予口服倍他乐克片治疗，对照组给予口服波依定治疗。结果治疗组治疗高血压的疗效明显优于对照组（P〈0．05），治疗组临床症状改善优于对照组（P〈0．05），两组不良反应发生情况差异无显著性意义。结论应用倍他乐克进行降压治疗疗效好，对患者症状改善明显，值得临床推广。Objective To analyze the efficacy of Betook for essential hypertension. Methods The patients were randomly divided into the treatment group and the control group. The cases were given Betook in the treatment group and Pencil in the control group. Results The better outcomes were achieved in treatment group （ P 〈 0.05 ） including the symptoms improved （P 〈 0. 05 ）. Conclusion A better therapeutic outcome can be reached for essential hypertension by Betook.

关 键 词：高血压 倍他乐克 波依定 

分 类 号：R542.2[医药卫生—心血管疾病] R735[医药卫生—内科学]